EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytokines Removal During Ex-Vivo Lung Perfusion: Initial Clinical Experience

Massimo Boffini, Matteo Marro, Erika Simonato, Fabrizio Scalini, Andrea Costamagna, Vito Fanelli, Cristina Barbero, Paolo Solidoro, Luca Brazzi, Mauro Rinaldi

Transplant International · 14.08.2023 · 36

DOI: 10.3389/ti.2023.10777 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant International, online erschienen am 14.08.2023. Verfasst von Massimo Boffini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Surgery Division, Surgical Sciences Department, Città della Salute e della Scienza, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Extracorporeal Circulation, Tissue and Organ Harvesting. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ex Vivo Lung Perfusion (EVLP) can be potentially used to manipulate organs and to achieve a proper reconditioning process. During EVLP pro-inflammatory cytokines have been shown to accumulate in perfusate over time and their production is correlated with poor outcomes of the graft. Aim of the present study is to investigate the feasibility and safety of cytokine adsorption during EVLP. From July 2011 to March 2020, 54 EVLP procedures have been carried out, 21 grafts treated with an adsorption system and 33 without. Comparing the grafts perfused during EVLP with or without cytokine adsorption, the use of a filter significantly decreased the levels of IL10 and GCSFat the end of the procedure. Among the 38 transplanted patients, the adsorption group experienced a significant decreased IL6, IL10, MCP1 and GCSF concentrations and deltas compared to the no-adsorption group, with a lower in-hospital mortality ( p = 0.03) and 1-year death rate ( p = 0.01). This interventional study is the first human experience suggesting the safety and efficacy of a porous polymer beads adsorption device in reducing the level of inflammatory mediators during EVLP. Clinical impact of cytokines reduction during EVLP must be evaluated in further studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal CirculationTissue and Organ HarvestingHumansCytokinesInterleukin-10PerfusionLung Transplantation

Stichwörter der Autor:innen

cytokinesex-vivo lung perfusioninflammationischemia-reperfusionlung transplantprimary graft dysfunction

Substanzen

CytokinesInterleukin-10

Autor:innen und Institutionen

  • Cardiac Surgery Division, Surgical Sciences Department, Città della Salute e della Scienza, University of Turin, Turin, Italy.
  • Anesthesiology and Intensive Care Division, Surgical Sciences Department, Città della Salute e della Scienza, University of Turin, Turin, Italy.
  • Pulmonology Division, Medical Sciences Department, Città della Salute e della Scienza, University of Turin, Turin, Italy.

Zitieren

APA

Boffini, M., Marro, M., Simonato, E., Scalini, F., Costamagna, A., Fanelli, V., Barbero, C., Solidoro, P., Brazzi, L., & Rinaldi, M. (2023). Cytokines Removal During Ex-Vivo Lung Perfusion: Initial Clinical Experience. Transplant International, 36. https://doi.org/10.3389/ti.2023.10777

Vancouver

Boffini M, Marro M, Simonato E, Scalini F, Costamagna A, Fanelli V, et al. Cytokines Removal During Ex-Vivo Lung Perfusion: Initial Clinical Experience. Transplant International. 2023;36. doi:10.3389/ti.2023.10777

BibTeX
@article{Boffini2023,
  author = {Boffini, Massimo and Marro, Matteo and Simonato, Erika and Scalini, Fabrizio and Costamagna, Andrea and Fanelli, Vito and Barbero, Cristina and Solidoro, Paolo and Brazzi, Luca and Rinaldi, Mauro},
  title = {Cytokines Removal During Ex-Vivo Lung Perfusion: Initial Clinical Experience},
  journal = {Transplant International},
  year = {2023},
  volume = {36},
  doi = {10.3389/ti.2023.10777}
}
Kostenlos starten →